Pat Andrews is a public company director and accomplished CEO with a strong background in the biopharmaceutical industry. Currently, Pat serves on the board of directors for Glenmark Pharmaceuticals and IGI, while also contributing to Oncolytics Biotech Inc. in various committees. Having previously held the role of CEO at Sumitomo Pharma Oncology, Pat led the company through significant stages of development and growth. Pat also served on the board and audit committee of GlycoMimetics, influencing key strategic decisions during its Phase III trials. Pat holds a Bachelor of Arts in History and Political Science from Brown University and an MBA in Finance from the University of Michigan.
This person is not in the org chart
This person is not in any teams
This person is not in any offices